The research aim to study in detail the motor, cognitive and affective modifications of Parkinsonian patients (compared to control subjects) at a moderate stage of the disease and to analyze by positron emission tomography (PET) imaging with the specific radioligand \[11C\]SB207145 the expression levels of this 5-HT4 receptor. At the same time, the study will monitor the impact of the 5-HTTLPR polymorphisms of Serotonin Transporter (SERT) and Brain-derived neurotrophic factor (BDNF) Val66Met on the expression of the 5-HT4 receptor in subjects.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
40
a consultation to assess cognitive and psycho-behavioral functions with questionnaires
10 mL intravenous whole blood collection in EDTA tube
Pet scan with the specific radioligand \[11C\]SB207145 and MRI
CERMEP
Bron, France
Hôpital des Charpennes Centre de Recherche Clinique "Vieillissement-Cerveau-Fragilité"
Lyon, France
Comparison of the expression of the 5-HT4 receptor between patients with mild to moderate Parkinson's disease to age-matched healthy controls
difference in the tracer \[11C\]SB207145 's binding, the specific binding of the tracer will be calculated for each voxel with respect to a reference zone (the white matter of the cerebellum).
Time frame: During MRI procedure
Description of 5-HT4 alterations related to motor symptoms
Relationship between the level of expression of the tracer and the clinical scores on the motor questionnaires
Time frame: During MRI procedure
Description of 5-HT4 alterations related to non-motor symptoms
Relationship between the level of expression of the tracer and the clinical scores on the non-motor questionnaires
Time frame: During MRI procedure
Description of 5-HT4 alterations related to cognitive symptoms
Relationship between the level of expression of the tracer and the clinical scores on the cognitive questionnaires
Time frame: During MRI procedure
Description of 5-HT4 alterations related to psychobehavioral symptoms
Relationship between the level of expression of the tracer and the clinical scores on the psychobehavioral questionnaires
Time frame: During MRI procedure
Description of 5-HT4 alterations related to SERT polymorphism data
Relationship between the level of expression of the tracer and SERT polymorphism data (5-HTTLPR polymorphism, evaluated as presence/absence)
Time frame: During MRI procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Description of 5-HT4 alterations related to BDNF polymorphism data
Relationship between the level of expression of the tracer and BDNF polymorphism data (Val66Met rs6265 polymorphism, evaluated as presence/absence)
Time frame: During MRI procedure